ELAN News

Elanco Animal Health (ELAN) Surges 7.6%: Is This an Indication of Further Gains?

Elanco Animal Health (ELAN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks | 5 months ago

Elanco Animal Health Incorporated (ELAN) Presents at 2026 KeyBanc Capital Markets Healthcare Forum Transcript

Seekingalpha | 5 months ago

Elanco Animal Health Incorporated (ELAN) Presents at Leerink Global Healthcare Conference 2026 Transcript

Seekingalpha | 5 months ago

Elanco Animal Health Incorporated (ELAN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Seekingalpha | 5 months ago

Elanco Animal Health Incorporated (ELAN) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Seekingalpha | 6 months ago

Elanco Animal Health Incorporated (ELAN) Presents at BofA Securities Animal Health Summit Transcript

Seekingalpha | 6 months ago

Elanco Animal Health Incorporated (ELAN) Q4 2025 Earnings Call Transcript

Seekingalpha | 6 months ago

Elanco Animal Health (ELAN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Elanco Animal Health (ELAN) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 6 months ago

Elanco Animal Health Incorporated (ELAN) Q4 Earnings and Revenues Surpass Estimates

Elanco Animal Health Incorporated (ELAN) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.14 per share a year ago.

Zacks | 6 months ago

Countdown to Elanco Animal Health (ELAN) Q4 Earnings: Wall Street Forecasts for Key Metrics

Besides Wall Street's top-and-bottom-line estimates for Elanco Animal Health (ELAN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.

Zacks | 6 months ago

Elanco Animal Health: Innovation-Led Growth Model Plus Credible Deleveraging Path

Elanco Animal Health earns a buy rating, driven by robust product innovation, commercial execution, and a credible deleveraging plan. ELAN's 'Big 6' innovation portfolio is set to contribute ~$1.1 billion in 2026 revenue, supporting margin expansion and portfolio renewal. Credelio Quattro and Zenrelia demonstrate ELAN's ability to capture share from incumbents, with rapid adoption and strong sequential growth.

Seekingalpha | 7 months ago

Are Medical Stocks Lagging Elanco Animal Health (ELAN) This Year?

Here is how Elanco Animal Health Incorporated (ELAN) and Tactile Systems Technology (TCMD) have performed compared to their sector so far this year.

Zacks | 8 months ago